Many Patients Continue Using Proton Pump Inhibitors After Negative Results From Tests for Reflux Disease
- 1 June 2012
- journal article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 10 (6) , 620-625
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Marked increase in proton pump inhibitors use in AustraliaPharmacoepidemiology and Drug Safety, 2010
- The development of a clinical outcomes survey research application: Assessment CenterSMQuality of Life Research, 2010
- Trends in Gastroesophageal Reflux Disease as Measured by the National Ambulatory Medical Care SurveyDigestive Diseases and Sciences, 2009
- Acid and non-acid reflux in Japanese patients with non-erosive reflux disease with persistent reflux symptoms, despite taking a double-dose of proton pump inhibitor: a study using combined pH-impedance monitoringJournal of Gastroenterology, 2009
- Esophageal-reflux monitoringGastrointestinal Endoscopy, 2009
- The effectiveness of esomeprazole 40 mg in patients with persistent symptoms of gastro-oesophageal reflux disease following treatment with a full dose proton pump inhibitorInternational Journal Of Clinical Practice, 2008
- Gastroesophageal Reflux DiseaseNew England Journal of Medicine, 2008
- Accounting for the effect of GERD symptoms on patients’ health-related quality of life: supporting optimal disease management by primary care physiciansInternational Journal Of Clinical Practice, 2007
- The Patient-Reported Outcomes Measurement Information System (PROMIS)Medical Care, 2007
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990